 
Sudarshan Chemical Industries Limited 
Registered Office:  7th Floor, Eleven West Panchshil, Survey No 25, Ne ar PAN Card Club Road, Baner, Pune 411 069, Maharas htra, India 
T:  +91 20 6828 1200   
|  E:  contact@sudarshan.com  |  www.sudarshan.com  |  CIN: L24119PN1951PLC008409  
 
14th  November , 2025  
  
BSE Limited  National Stock Exchange of India Limited  
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Blo ck G, 
Dalal Street, Mumbai – 400 001  Bandra Kurla Comple x,  
Scrip Code - 506655  Bandra (East), Mumbai – 400 051 
 Scrip Symbol - SUDARSCHEM 
 
Dear Sir / Madam, 
 
Sub: Monitoring Agency Report for the quarter ended  30
th  September, 2025 on the 
utilisation of proceeds raised through issuance of equity shares by way of               
Qualified Institutions Placement Issue of the Company 
  
Pursuant to Regulation 32(6) of SEBI (Listing Oblig ations and Disclosure Requirements), 
Regulations, 2015 read with Regulations 173A of SEB I (Issue of Capital and Disclosure 
Requirements) Regulations, 2018, please find enclos ed herewith the Monitoring Agency 
Report dated 14th  November, 2025, issued by CRISIL Ratings Limited ( Monitoring Agency), 
with respect to utilization of the proceeds raised through issuance of equity shares by way of 
Qualified Institutions Placement Issue ((“QIP Issue ") of the Company, for the quarter ended                                        
30th  September, 2025. 
 
Please note that out of the total proceeds of QIP I ssue amounting to ₹80,000.00 Lakhs,                
₹82.81 Lakhs which remained unutilized as on 30 th  June, 2025, have been fully utilized by the 
Company for the same objects or purposes for which funds were raised and there is no 
unutilized amount as at the end of the quarter ended 30 th  September, 2025. 
 
This is for your information and records. 
 
Thanking You,  
Yours faithfully,  
For SUDARSHAN CHEMICAL INDUSTRIES LIMITED 
 
 
 
MANDAR VELANKAR 
GENERAL COUNSEL AND COMPANY SECRETARY  
 
  Encl. as above. 
              
 
1 
 
 
 
 
 
 
 
 
Monitoring Agency Report 
for  
Sudarshan Chemical Industries Limited  
for the quarter ended  
September 30, 2025 
  
 
2 
 
 
CRL/MAR/EMULIM/2025-26/1567 
 
November 14, 2025 
 
To 
Sudarshan Chemical Industries Limited 
7th Floor, Eleven West Panchshil,  
Survey No. 25, Near PAN Card Club Road,  
Baner, Pune, Maharashtra, 411069 
 
Dear Sir, 
 
Final Monitoring Agency Report for the quarter ended September 30, 2025 - in relation to the Qualified 
Institutional Placement (“QIP”) of Sudarshan Chemical Industries Limited (“the Company”) 
 
Pursuant to Regulation 173A of SEBI (lssue of Capital and Disclosure Requirements) Regulations, 2018 (“ SEBI 
ICDR Regulations ”) and Monitoring Agency Agreement dated January 23, 2025, enclosed herewith the  Final 
Monitoring Agency Report , issued by Crisil Ratings Limited, Monitoring Agency, as per Schedule XI of the SEBI 
ICDR Regulations towards utilization of proceeds of QIP for the quarter ended September 30, 2025.  
 
Request you to kindly take the same on records. 
 
Thanking you, 
For and on behalf of Crisil Ratings Limited  
 
 
Shounak Chakravarty 
Director, Ratings (LCG) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  

 
3 
 
Final Report of the Monitoring Agency (MA) 
 
Name of the issuer: Sudarshan Chemical Industries Limited 
 
For quarter ended: September 30, 2025 
 
Name of the Monitoring Agency: Crisil Ratings Limited 
 
(a) Deviation from the objects: No  
 
(b) Range of Deviation: Not applicable 
 
Declaration: 
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of  the 
issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and  
reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ 
statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no 
responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do 
not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this 
report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the 
agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the 
Companies Act, 2013. 
 
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains  
and may receive separate compensation for its ratings and certain credit -related analyses. We confirm that we do not perceive 
any conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the 
issuer. 
 
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. 
There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the 
Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer 
and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA 
takes no responsibility for such comments of the issuer’s Management/Board. 
 
 
Signature:  
Name and designation of the Authorized Signatory: Shounak Chakravarty 
Designation of Authorized person/Signing Authority: Director, Ratings (LCG) 
 
 
 
 
 
 
 
 
 
 
  

 
4 
 
1) Issuer Details: 
 
     Name of the issuer:    Sudarshan Chemical Industries Limited 
 
Names of the promoter:    Mr. Rajesh Balkrishna Rathi 
 
Industry/sector to which it belongs:                Dyes and Pigments 
 
2) Issue Details 
 
Issue Period: January 23, 2025, to January 28, 2025 
 
Type of issue (public/rights):   Qualified Institutional Placement 
 
Type of specified securities:                 Equity Shares 
 
QIP Grading, if any:    NA 
 
Issue size: This gross issue of 74,76,635 Equity Shares at  a price of 
Rs.1,070/-per share aggregating to Rs 80,000.00 Lakh (Net 
Proceeds of Rs 78,565.26^ Lakh)* 
 
*Crisil Ratings shall be monitoring the  gross proceeds amount as per placement document dated 28 th January 2025 (“Offer 
Document”).  
   
^Net proceeds have been revised from Rs 78,565.26 lakh to Rs 78,636.03 lakh, on account of actual issue expenses being lower 
than estimated as disclosed in the Placement document dated January 28, 2025. 
 
3) Details of the arrangement made to ensure the monitoring of gross proceeds: 
Particulars Reply 
Source of information 
/ certifications 
considered by 
Monitoring Agency for 
preparation of report 
Comments of 
the Monitoring 
Agency 
Comments of 
the Board of 
Directors 
Whether all utilization is as per 
the disclosures in the offer 
document? 
Yes 
Offer Document,  
Bank Statement,  
Management 
Undertaking,  
Peer Reviewed 
Independent Chartered 
Accountant Certificate^ 
Utilization is as 
per the object of 
the issue i.e. 
GCP and issue 
expense as 
specified in 
Placement 
document dated  
January 28, 2025 
No Comment 
Whether shareholder approval 
has been obtained in case of 
material deviations # from 
expenditures disclosed in the 
offer document? 
NA 
Management 
Undertaking, 
Peer Reviewed 
Independent Chartered 
Accountant Certificate^ 
No Comment No Comment 
 
5 
 
Particulars Reply 
Source of information 
/ certifications 
considered by 
Monitoring Agency for 
preparation of report 
Comments of 
the Monitoring 
Agency 
Comments of 
the Board of 
Directors 
Whether the means of Finance for 
the disclosed objects of the issue 
has changed? 
No No Comment No Comment 
Is there any major deviation 
observed over the earlier 
monitoring agency reports? 
No 
Management 
Undertaking, 
Peer Reviewed 
Independent Chartered 
Accountant Certificate^ 
No Comment No Comment 
Whether all 
Government/statutory approvals 
related to the object(s) have been 
obtained? 
Yes No Comment No Comment 
Whether all arrangements 
pertaining to technical 
assistance/collaboration are in 
operation? 
NA No Comment No Comment 
Are there any favourable events 
improving the viability of these 
object(s)? 
NA No Comment No Comment 
Are there any unfavourable 
events affecting the viability of 
these object(s)? 
NA No Comment No Comment 
Is there any other relevant 
information that may materially 
affect the decision making of the 
investors? 
NA No Comment No Comment 
# Where material deviation may be defined to mean: - 
(a) Deviation in the objects or purposes for which the funds have been raised.  
(b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer 
documents. 
NA represents Not Applicable 
 
^ On the basis of Certificate dated November 06, 2025 , issued by M/s P V Deo & Associates LLP, Chartered Accountants 
(Firm Registration Number: W100637), Peer Reviewed Independent Chartered Accountant. 
 
 
6 
 
4) Details of object(s) to be monitored: 
 
i. Cost of the object(s):  
 
Sr. 
No. 
 
Item 
Head 
Source of 
information/ 
certification 
considered by 
MA for 
preparation of 
report 
Original 
cost  
(as per the 
Offer 
Document) 
(Rs in Lakh) 
Revised 
Cost 
(Rs in 
Lakh) 
Comment 
of the MA 
Comments of the Board of Directors 
Reason of 
Cost 
revision 
Proposed 
financing 
option 
Particulars 
of firm 
arrange-
ments 
made 
1 
Investment in our Material 
Subsidiary, Sudarshan 
Europe B.V. for part funding 
the proposed acquisition of 
global pigment business 
operations of the Heubach 
Group, through Sudarshan 
Europe B.V or its 
subsidiaries (“Proposed 
Acquisition”), including all 
associated costs in relation 
to the Proposed Acquisition 
 
Management 
undertaking, 
Peer-
reviewed 
Independent 
Chartered 
Accountant 
Certificate ^, 
Placement 
Document 
 
32,500.00 32,500.00 No revision No 
Comment 
No 
Comment 
No 
Comment 
2 
Repayment / pre-payment, 
in part or in full, of certain 
outstanding borrowings 
availed by our Company 
28,500.00 28,500.00 No revision No 
Comment 
No 
Comment 
No 
Comment 
3 General Corporate Purposes 
(GCP) 17,565.26 17,636.03 Refer 
Note 1 
No 
Comment 
No 
Comment 
No 
Comment 
 Sub-Total 78,565.26 78,636.03 - No 
Comment 
No 
Comment 
No 
Comment 
4 Issue Expense 1,434.74 1,363.97 Refer 
Note 1 
No 
Comment 
No 
Comment 
No 
Comment 
 Total - 80,000.00 80,000.00 - - - - 
 
^Certificate dated  November 06, 2025 , issued by  M/s P V Deo & Associates LLP, Chartered Accountants (Firm Registration Number: 
W100637), Peer Reviewed Independent Chartered Accountant 
 
Note 1: Pursuant to the Placement Document dated January 28, 2025, filed by the Company, an estimated amount of Rs 1,434.74 lakhs was  
allocated towards issue-related expenses. However, as of the quarter ended September 30, 2025, the actual expenses incurred were found to be Rs 
1,363.97 lakhs. Consequently, the resultant amount was added to the General Corporate Purposes (GCP) cost, as approved by the Board of 
Directors through a resolution dated September 23, 2025 
 
#The amount utilised for general corporate purposes does not exceed 25% of the Issue Proceeds (amounting to Rs 20,000 Lakh) from the Fresh  
Issue. 
 
  
 
7 
 
ii. Progress in the object(s): 
 
 
Sr. 
No. 
 
 
Item Head# 
Source of 
information/ 
certifications 
considered by 
Monitoring 
Agency for 
preparation of 
report 
 
Amount as 
proposed 
in the Offer 
Document 
(Rs in 
Lakh) 
Amount utilized 
(Rs in Lakh) Total 
unutilized 
amount 
(Rs in 
Lakh) 
 
Comments of the 
Monitoring 
Agency 
Comments of the 
Board of Directors 
As at 
beginning 
of the 
quarter 
 
During 
the 
quarter 
 
At the 
end 
of the 
quarter 
 
Reasons for 
idle funds 
 
Proposed 
course of 
action 
1 
Investment in our Material 
Subsidiary, Sudarshan 
Europe B.V. for part 
funding the proposed 
acquisition of global 
pigment business 
operations of the Heubach 
Group, through 
Sudarshan Europe B.V or 
its subsidiaries (“Proposed 
Acquisition”), including 
all associated costs in 
relation to the Proposed 
Acquisition 
Management 
undertaking, 
Peer-reviewed 
 Independent 
Chartered 
Accountant 
Certificate ^, 
Placement 
Document, 
Bank Statements 
 
32,500.00 32,500.00 Nil 32,500.00 Nil 
Fully utilised 
during   quarter 
ended March 31, 
2025 
No 
Comment 
No 
Comment 
2 
Repayment / pre-
payment, in part or in full, 
of certain outstanding 
borrowings availed by our 
Company 
28,500.00 28,500.00 Nil 28,500.00 Nil 
Fully utilised 
during   quarter 
ended March 31, 
2025 
No 
Comment 
No 
Comment 
3 General Corporate 
Purposes (GCP) 17,636.03 17,565.26 
 
70.77 
      
17,636.03 Nil 
Refer  
Note 1 
& 2 
No 
Comment 
No 
Comment 
 Sub Total  78,636.03    78,565.26 70.77 
 78,565.26 Nil - - - 
4 Issue Expense  1,363.97 1351.92 12.05 1,363.97 Nil 
Refer  
Note 1 
above 
No 
Comment 
No 
Comment 
 Total  80,000.00  79,917.18 82.82 80,000.00 Nil - - - 
 
^Certificate dated November 06, 2025 , issued by M/s P V Deo & Associates LLP, Chartered Accountants (Firm Registration Number: W100637), 
Peer Reviewed Independent Chartered Accountant 
 
Note 2: During the reported quarte r, Rs 70.77 lakh from the company’s  QIP Escrow account  was transferred to  Company’s current account/cash 
credit account maintained with the Axis Bank account for utilising towards the object of the issue, primarily for operational ease. As of the quarter  
end, the entire amount transferred to the company's internal account has been fully utilized.  
 
 *All figures in the above table are rounded off to nearest two decimal places 
 
  
 
8 
 
#Brief description of objects: 
Object of the Issue Description of objects as per the offer document filed by the issuer  
Investment in our Material 
Subsidiary, Sudarshan Europe 
B.V. for part funding the 
proposed acquisition of global 
pigment business operations of 
the Heubach Group through 
Sudarshan Europe B.V or its 
subsidiaries, including all 
associated costs in relation to the 
Proposed Acquisition 
The proposed transaction comprises of acquisition by Sudarshan Europe B.V of (i ) assets 
and business operations of (a) Heubach Colorants Germany GmbH, (b) Heubach GmbH 
(c) Dr. Hans Heubach GmbH, and (d) Heubach Group GmbH and participations held by 
Heubach Holding Switzerland AG, in downstream group companies in various countries 
from insolvency administrator in the aforesaid countries; (ii) 100% shareholding of 
Heubach Holdings S.a.r.l., a Luxemburg based Heubach Group company having 
investments in shareholding in companies based in India and USA. Heubach Group is 
engaged in manufact uring of speciality chemicals consisting of organic pigments, 
inorganic pigments, dyes, dispersions and anti -corrosion pigments. Post Heubach 
Acquisition, The company/group will have a comprehensive pigment portfolio of and a 
presence in markets including Europe and the Americas. 
Repayment / pre-payment, in 
part or in full, of certain 
outstanding borrowings availed 
by our Company 
The selection of borrowings proposed to be repaid/pre -paid amongst the borrowing 
arrangements availed is based on various factors including (i) cost of borrowing, including 
applicable interest rates, (ii) any conditions attached to the borrowings restricti ng our 
ability to prepay the borrowings and time taken to fulfil or obtain waiver for such 
requirements, (iii) ,terms and conditions of consents or waivers, (iv) levy of prepayment 
penalties and quantum thereof and (v) other commercial considerations including, among 
others, the amount of the loans outstanding and the remaining tenor of the loan  
General Corporate Purposes 
(GCP) 
As per placement document filed by the Company, General corporate purposes may 
include, but are not restricted to, 
i. funding growth opportunities, 
ii. business development initiatives,  
iii. redemption of outstanding non-convertible debentures, 
iv. working capital requirement of the Company and its Subsidiaries including future 
subsidiaries  
v. consideration for Open Offer 
vi. capital expenditure on integration of target company with the Company including 
consulting fees 
 
The quantum and timing of utilisation of funds towards each of the above purposes will 
be determined by our Board, based on the amount actually available under this head and 
the business requirements of the Company, from time to time, subject to compliance with 
applicable law 
 
 
9 
 
iii. Deployment of unutilised proceeds: 
  
Based on Management undertaking & Certificate dated November 06, 2025, issued by M/s P V Deo & Associates LLP, Chartered 
Accountants (Firm Registration Number: W100637), Peer Reviewed Independent Chartered Accountant 
 
S.  
No. 
Type of instrument where 
amount is invested 
Amount 
invested 
(Rs in 
Lakh)  
Maturity 
date 
Earnings 
(Rs in 
Lakh) 
Return on 
Investment 
(%) 
Market value as at 
the end of quarter 
(Rs in Lakh) 
Not applicable 
 
Note 3: No issue proceeds stand unutilized as at the end of reported quarter, and there is Nil balance in the Monitoring Account and Public 
Issue account of the Company. Hence, this is the final MA report being issued to the Company. 
 
*All figures in the above table are rounded off to nearest two decimal places 
 
iv. Delay in implementation of the object(s):  
 
On the basis of Management undertaking & Certificate dated November 06, 2025, issued by M/s P V Deo & Associates LLP, 
Chartered Accountants (Firm Registration Number: W100637), Peer Reviewed Independent Chartered Accountant 
 
 
Object(s) 
Completion Date  
Delay  
(no. of days/ 
months) 
Comments of the Board of 
Directors 
As per the 
Offer 
Document 
 
Actual Reason of 
delay 
Proposed 
course of 
action 
Not applicable 
 
5) Details of utilization of proceeds stated as General Corporate Purpose (GCP) amount in the offer document:  
 
On the basis of Management undertaking & Certificate dated November 06, 2025, issued by M/s P V Deo & Associates LLP, 
Chartered Accountants (Firm Registration Number: W100637), Peer Reviewed Independent Chartered Accountant 
 
S. No. Item heads Amount  
(Rs in Lakh) Remarks 
 
 
  1 
 Working capital 70.77 
• Payment to Raw Material Suppliers  
• The Board of Directors of the Company vide 
resolution dated November 12, 2025, has 
approved the quantum of utilization of GCP 
towards mentioned item heads in line with the 
disclosure provided in the placement 
document  
 
  
 
10 
 
 
 
Disclaimers: 
 
a) This Report is prepared by Crisil Ratings Limited (hereinafter referred to as "Monitoring Agency” / “MA" / 
“CRL”). The MA has taken utmost care to ensure accuracy and objectivity while developing this Report based on the 
information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. 
The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in 
any manner whatsoever.  
b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to inaccurate 
assessments. For the purpose of this Report, MA has relied upon the information provided by the management 
/officials/ consultants of the Issu er and third-party sources like statutory auditors  (or from peer reviewed CA firms)  
appointed by the Issuer believed by it to be accurate and reliable. 
c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the MA which 
accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The MA is also not 
responsible for any errors in transmission and specifically states that it, or its directors, employees do not have any 
financial liabilities whatsoever to the users of this Report. 
d) The MA and its affiliates do not act as a fiduciary. The MA and its affiliates also do not act as an expert to the extent 
defined under Section 2(38) of the Companies Act, 2013. While the MA has obtained information from sources it 
believes to be reliable,  it does not perform an audit and undertakes no independent verification of any information/ 
certifications/ statements it receives from auditors (or from peer reviewed CA firms), lawyers, chartered engineers or 
other experts, and relies on in its reports. 
e) The MA or its affiliates may have other commercial transactions with the entity to which the report pertains. As an 
example, the MA may rate the issuer or any debt instruments / facilities issued or proposed to be issued by the issuer 
that is subject matte r of this report. The MA may receive separate compensation for its ratings and certain credit -
related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors.  
f) The MA report is intended for the jurisdiction of India only. This report does not constitute an offer of services. 
Without limiting the generality of the foregoing, nothing in the report is to be construed as CRL providing or 
intending to provide any serv ices in jurisdictions outside India, where it does not have the necessary licenses and/or 
registration to carry out its business activities referred to above.  
g) Access or use of this report does not create a client relationship between CRL and the user.  
h) CRL is not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. 
In preparing this report, MA has not taken into consideration the objectives or particular needs of any particular user.  
i) It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report 
is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities 
or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report 
should not be a basis for any investment decision within the meaning of any law or regulation (including the laws 
and regulations applicable in the US). 
j) The report comprises professional opinion of CRL as of the date they are expressed, based on the information received 
from the issuer and other sources considered reliable by CRL. Any opinions expressed here are in good faith, are subject 
to change without  notice, and are only current as of the stated date of their issue. The report does not constitute 
statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment 
decisions. 
k) Neither CRL nor its affiliates, third -party providers, as well as their directors, officers, shareholders, employees or 
agents guarantee the accuracy, completeness or adequacy of the report, and shall not have any liability for any errors, 
omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the 
report. CRL and each aforesaid party disclaims any and all express or implied warranties, including but not limited 
to any warranties of merchantabilit y, suitability or fitness for a particular purpose or use or use. In no event shall 
CRL or any aforesaid party be liable to any user for any direct, indirect, incidental, exemplary, compensatory, 
punitive, special or consequential damages, costs, expenses,  legal fees or losses (including, without limitation, lost 
 
11 
 
income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of 
the possibility of such damages.  
l) CRL has established policies and procedures to maintain the confidentiality of certain non-public information received 
in connection with the preparation of this report. CRL has in place a code of conduct and policies for managing conflict 
of interest.  
m) Unless required under any applicable law, this report should not be reproduced or redistributed to any other person 
or in any form without prior written consent from CRL. 
n) By accepting a copy of this Report, the recipient accepts the terms of this Disclaimer, which forms an integral part of 
this Report. 
 
